Ischemic Heart Disease
📧 Sign up to get email alerts when something new happens for Ischemic Heart Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-06-09Clinical Trial Update: Association Between Framingham Risk Score, hsCRP and Vascular Inflammation: Analysis With 18F-Fluorodeoxyglucose Positron Emission Tomography
A completed clinical trial analyzed the association between Framingham Risk Score, hsCRP, and vascular inflammation measured by 18F-FDG PET …
-
CLINICAL_TRIALS trial_result · 2010-06-04Clinical Trial Update: The Prognostic Significance of a Fragmented QRS Complex After Primary Percutaneous Coronary Intervention
This update evaluates whether fragmented QRS complexes after primary percutaneous coronary intervention have prognostic value for major adve…
-
FDA approval · 2010-05-18FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's supplemental application for clopidogrel bisulfate, a generic version of clopidogrel. The ap…
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial) [Phase 3]
The EuroSTAR Phase 3 trial evaluating a cobalt-based antiproliferative stent for restenosis in symptomatic ischemic heart disease has comple…
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: The Effect of Enhanced External Counter Pulsation on Left Ventricular Systolic and Diastolic Function [NA]
A clinical trial update describes evaluating enhanced external counterpulsation (EECP) and its effects on left ventricular systolic and dias…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-04-16FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for EFFIENT (prasugrel hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2010-03-31Clinical Trial Update: Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing rosiglitazone to a sulfonylurea in patients with heart disease and type 2 diabetes assessed progression of atheros…
-
EMA safety_alert · 2010-03-25European Medicines Agency recommends precautionary recall of batches of clopidogrel-containing medicines from Acino Pharma GmbH
EMA recommends a precautionary recall of certain batches of clopidogrel-containing medicines from Acino Pharma GmbH due to quality concerns.
-
CLINICAL_TRIALS trial_result · 2010-02-25Clinical Trial Update: The Impact of Caffeine on Brachial Endothelial Function in Healthy Subjects and in Patients With Ischemic Heart Disease [Phase 3]
A Phase 3 trial evaluating the impact of caffeine on brachial endothelial function in healthy subjects and in patients with ischemic heart d…
-
CLINICAL_TRIALS trial_result · 2010-02-11Clinical Trial Update: DESWT-Pilot Study on the Safety of Myocardial Regeneration by Direct Epicardial Shock Wave Therapy in Combination With Coronary Artery Bypass Grafting [NA]
This entry covers a pilot clinical trial evaluating the safety of myocardial regeneration using direct epicardial shock wave therapy in comb…
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Cell Therapy in Chronic Ischemic Heart Disease [Phase 3]
A Phase 3 clinical trial evaluating a cell therapy for ischemic heart disease has been terminated.
-
FDA approval · 2009-12-23FDA Approved: LEXISCAN — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for LEXISCAN (regadenoson) submitted by Astellas Pharma US, Inc.
-
CLINICAL_TRIALS trial_result · 2009-11-02Clinical Trial Update: Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts [NA]
This document reports the completion of the Symbiot III trial, a prospective randomized study evaluating the Symbiot covered stent system in…
-
CLINICAL_TRIALS trial_result · 2009-10-29Clinical Trial Update: CoStar Catheter System Evaluation [Phase 3]
Phase 3 clinical trial update for the CoStar Catheter System in symptomatic ischemic heart disease; the study has been terminated.
-
FDA approval · 2009-10-22FDA Approved: RAMIPRIL — Supplemental Application (Chartwell RX, LLC.)
FDA approved a supplemental application for RAMIPRIL submitted by Chartwell RX, LLC., indicating approval of a supplemental filing related t…
-
CLINICAL_TRIALS research · 2009-10-21Clinical Trial Update: Arrested Versus Beating Heart Techniques in Coronary Revascularisation [Phase 3]
A Phase 3 clinical trial compares arrested (cardioplegic) versus beating-heart techniques in coronary revascularisation; the update provides…
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention [Phase 4]
Phase 4 clinical trial update evaluating optimized antiplatelet therapy after percutaneous coronary intervention; the study status is comple…
-
CLINICAL_TRIALS trial_result · 2009-10-08Clinical Trial Update: Effect of Remote Preconditioning in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery [Phase 1]
Phase 1 clinical trial evaluating the effect of remote preconditioning in patients undergoing off-pump coronary artery bypass graft surgery;…
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: Bridging Therapy in Patients at High Risk for Stent Thrombosis Undergoing Surgery
Clinical trial update regarding bridging therapy for patients at high risk of stent thrombosis undergoing surgery.
-
CLINICAL_TRIALS other · 2009-08-13Clinical Trial Update: The SOURT OUT IV TRIAL [NA]
Clinical trial NCT00552877 (SOURT OUT IV TRIAL) sponsored by Odense University Hospital related to ischemic heart disease and coronary ather…
-
CLINICAL_TRIALS research · 2009-08-06Clinical Trial Update: Effect of Remote Ischemic Preconditioning on Cognitive Function After Off-Pump Coronary Artery Bypass Graft [Phase 1]
Phase 1 clinical trial update assessing whether remote ischemic preconditioning improves cognitive function after off-pump CABG in patients …
-
CLINICAL_TRIALS trial_result · 2009-06-24Clinical Trial Update: VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study [Phase 1]
Phase 1 feasibility study evaluating the iCoapsys Delivery system for valvular and ventricular improvement in patients with mitral valve reg…
-
CLINICAL_TRIALS trial_result · 2009-05-12Clinical Trial Update: The Ischemia Modified Albumin In Diagnosing Ischemic New Events
A clinical trial evaluating ischemia-modified albumin for diagnosing new ischemic events was terminated.
-
CLINICAL_TRIALS trial_result · 2009-05-06Clinical Trial Update: Clopidogrel Versus Adenosin in Non Urgent Percutaneous Coronary Intervention (PCI) [Phase 3]
A Phase 3 clinical trial compares clopidogrel to adenosine in non-urgent percutaneous coronary intervention, sponsored by the University of …
-
FDA approval · 2009-04-29FDA Approved: TECHNETIUM TC 99M SESTAMIBI — Original Application (Jubilant Draximage (USA) Inc.)
FDA approved Jubilant Draximage (USA) Inc.'s original ANDA for Technetium Tc-99m Sestamibi, a radiopharmaceutical used in myocardial perfusi…